The customer stated that they received erroneous results for two patient samples tested for the elecsys ca 15-3 ii assay (ca 15-3) and the elecsys total psa immunoassay (tpsa) on a cobas 6000 e 601 module (e601).The erroneous results were reported outside of the laboratory.It was stated that the low results did not fit the clinical picture of the patients.The first sample initially resulted as > 100 ng/ml for tpsa on (b)(6) 2016.The sample was diluted 1:10 and repeated, resulting as 0.53 ng/ml.The second sample, from a (b)(6) female born on (b)(6) 1955, initially resulted as 1.00 u/ml accompanied by a data flag for ca 15-3 on (b)(6) 2017.The sample was repeated, resulting as 24.51 u/ml for ca 15-3 on (b)(6) 2017.The patients were not adversely affected.The ca 15-3 reagent lot number was 161228.The tpsa reagent lot number was 135984.The expiration dates for these reagents were asked for, but not provided.No crystals were found in the system reagent cups and the mixer was found to be within specifications.Calibrations were within acceptable limits and controls were within specifications.Samples were tested from primary tubes which were processed on a cobas p612 pre-analytics system.
|
A specific root cause could not be determined based on the provided information.Additional information required for the investigation was requested but not provided.The investigation found no other cases for the same incident within the last six months.Possible root causes for this event may be insufficient electromagnetic interference compliance, sample quality, improper handling of the reagent or system reagents, insufficient maintenance, or contamination of the environment with the analyte.
|